- Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: u.s. Food and drug administration drug approval summary. Thornton, K., Kim, G., Maher, V.E., Chattopadhyay, S., Tang, S., Moon, Y.J., Song, P., Marathe, A., Balakrishnan, S., Zhu, H., Garnett, C., Liu, Q., Booth, B., Gehrke, B., Dorsam, R., Verbois, L., Ghosh, D., Wilson, W., Duan, J., Sarker, H., Miksinski, S.P., Skarupa, L., Ibrahim, A., Justice, R., Murgo, A., Pazdur, R. Clin. Cancer Res. (2012)